Loading…

Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors

Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survi...

Full description

Saved in:
Bibliographic Details
Published in:Thoracic cancer 2021-12, Vol.12 (23), p.3110-3120
Main Authors: Zhu, Chao, Ding, Jialin, Wang, Songping, Qiu, Qingtao, Ji, Youxin, Wang, Linlin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73
cites cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73
container_end_page 3120
container_issue 23
container_start_page 3110
container_title Thoracic cancer
container_volume 12
creator Zhu, Chao
Ding, Jialin
Wang, Songping
Qiu, Qingtao
Ji, Youxin
Wang, Linlin
description Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF. Methods The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation. Results For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones. Conclusions The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas. The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions f
doi_str_mv 10.1111/1759-7714.14115
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d</doaj_id><sourcerecordid>2604953177</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</originalsourceid><addsrcrecordid>eNqFkctr3DAQxk1paUKac29F0PMmkvWyL4WwfQUCvaRnMXo5WmzLlbxbAvnjK6_TpTl1LpJG3_w0o6-q3hN8RUpcE8nbjZSEXRFGCH9VnZ8yr097LM6qy5x3uARtWlzzt9UZZYJJRuR59fTZHVwfp8GNM4LRogP0wcIc4oiiR4CmFLsx5jkYNMYhdgkG5GNCQ9F1I5Qql-P0AJ2DHvmQ530PSEN2FhVEAhviEEw-sk0fxmAWHZg5pvyueuOhz-7yeb2ofn79cr_9vrn78e12e3O3MZxSvuGYad0ITi1w7bltiNSsDOZxQ3RLLG1FQxrXSAMSLNNe43IkFvu6dcJKelHdrlwbYaemFAZIjypCUMdETJ2CVCbsnbKcg-Gc1II71poaZK0lbwoKC2KZLaxPK2va68FZU_4tQf8C-vJmDA-qiwfVCCpqggvg4zMgxV97l2e1i_s0lvlVLTBrOSVyafl6VZkUc07On14gWC3uq8VftXitju6Xig__NnbS__W6CPgq-B169_g_nrrf3qzgP4l4u00</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604953177</pqid></control><display><type>article</type><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</creator><creatorcontrib>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</creatorcontrib><description>Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF. Methods The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation. Results For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones. Conclusions The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas. The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</description><identifier>ISSN: 1759-7706</identifier><identifier>EISSN: 1759-7714</identifier><identifier>DOI: 10.1111/1759-7714.14115</identifier><identifier>PMID: 34647417</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Aged ; Body mass index ; Cancer therapies ; Chemotherapy ; Disease-Free Survival ; Esophageal cancer ; esophageal fistula ; Esophageal Fistula - diagnostic imaging ; Esophageal Fistula - pathology ; Esophageal Neoplasms - diagnostic imaging ; Esophageal Neoplasms - pathology ; Female ; Fistula ; Humans ; Male ; Medical prognosis ; Medical records ; Middle Aged ; Neutrophils ; Nomograms ; Open source software ; Original ; Patients ; Prognosis ; prognostic factors ; Proportional Hazards Models ; Radiomics ; Retrospective Studies ; Risk Factors ; Statistical analysis ; Survival analysis ; Tomography, X-Ray Computed ; Tumors</subject><ispartof>Thoracic cancer, 2021-12, Vol.12 (23), p.3110-3120</ispartof><rights>2021 The Authors. published by China Lung Oncology Group and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</citedby><cites>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</cites><orcidid>0000-0001-7879-7281</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2604953177/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2604953177?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34647417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Chao</creatorcontrib><creatorcontrib>Ding, Jialin</creatorcontrib><creatorcontrib>Wang, Songping</creatorcontrib><creatorcontrib>Qiu, Qingtao</creatorcontrib><creatorcontrib>Ji, Youxin</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><title>Thoracic cancer</title><addtitle>Thorac Cancer</addtitle><description>Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF. Methods The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation. Results For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones. Conclusions The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas. The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</description><subject>Aged</subject><subject>Body mass index</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Disease-Free Survival</subject><subject>Esophageal cancer</subject><subject>esophageal fistula</subject><subject>Esophageal Fistula - diagnostic imaging</subject><subject>Esophageal Fistula - pathology</subject><subject>Esophageal Neoplasms - diagnostic imaging</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Female</subject><subject>Fistula</subject><subject>Humans</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Neutrophils</subject><subject>Nomograms</subject><subject>Open source software</subject><subject>Original</subject><subject>Patients</subject><subject>Prognosis</subject><subject>prognostic factors</subject><subject>Proportional Hazards Models</subject><subject>Radiomics</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Statistical analysis</subject><subject>Survival analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumors</subject><issn>1759-7706</issn><issn>1759-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkctr3DAQxk1paUKac29F0PMmkvWyL4WwfQUCvaRnMXo5WmzLlbxbAvnjK6_TpTl1LpJG3_w0o6-q3hN8RUpcE8nbjZSEXRFGCH9VnZ8yr097LM6qy5x3uARtWlzzt9UZZYJJRuR59fTZHVwfp8GNM4LRogP0wcIc4oiiR4CmFLsx5jkYNMYhdgkG5GNCQ9F1I5Qql-P0AJ2DHvmQ530PSEN2FhVEAhviEEw-sk0fxmAWHZg5pvyueuOhz-7yeb2ofn79cr_9vrn78e12e3O3MZxSvuGYad0ITi1w7bltiNSsDOZxQ3RLLG1FQxrXSAMSLNNe43IkFvu6dcJKelHdrlwbYaemFAZIjypCUMdETJ2CVCbsnbKcg-Gc1II71poaZK0lbwoKC2KZLaxPK2va68FZU_4tQf8C-vJmDA-qiwfVCCpqggvg4zMgxV97l2e1i_s0lvlVLTBrOSVyafl6VZkUc07On14gWC3uq8VftXitju6Xig__NnbS__W6CPgq-B169_g_nrrf3qzgP4l4u00</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Zhu, Chao</creator><creator>Ding, Jialin</creator><creator>Wang, Songping</creator><creator>Qiu, Qingtao</creator><creator>Ji, Youxin</creator><creator>Wang, Linlin</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7879-7281</orcidid></search><sort><creationdate>202112</creationdate><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><author>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Body mass index</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Disease-Free Survival</topic><topic>Esophageal cancer</topic><topic>esophageal fistula</topic><topic>Esophageal Fistula - diagnostic imaging</topic><topic>Esophageal Fistula - pathology</topic><topic>Esophageal Neoplasms - diagnostic imaging</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Female</topic><topic>Fistula</topic><topic>Humans</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Neutrophils</topic><topic>Nomograms</topic><topic>Open source software</topic><topic>Original</topic><topic>Patients</topic><topic>Prognosis</topic><topic>prognostic factors</topic><topic>Proportional Hazards Models</topic><topic>Radiomics</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Statistical analysis</topic><topic>Survival analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Chao</creatorcontrib><creatorcontrib>Ding, Jialin</creatorcontrib><creatorcontrib>Wang, Songping</creatorcontrib><creatorcontrib>Qiu, Qingtao</creatorcontrib><creatorcontrib>Ji, Youxin</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Thoracic cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Chao</au><au>Ding, Jialin</au><au>Wang, Songping</au><au>Qiu, Qingtao</au><au>Ji, Youxin</au><au>Wang, Linlin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</atitle><jtitle>Thoracic cancer</jtitle><addtitle>Thorac Cancer</addtitle><date>2021-12</date><risdate>2021</risdate><volume>12</volume><issue>23</issue><spage>3110</spage><epage>3120</epage><pages>3110-3120</pages><issn>1759-7706</issn><eissn>1759-7714</eissn><abstract>Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF. Methods The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation. Results For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones. Conclusions The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas. The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</abstract><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>34647417</pmid><doi>10.1111/1759-7714.14115</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7879-7281</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1759-7706
ispartof Thoracic cancer, 2021-12, Vol.12 (23), p.3110-3120
issn 1759-7706
1759-7714
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d
source Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database; PubMed Central
subjects Aged
Body mass index
Cancer therapies
Chemotherapy
Disease-Free Survival
Esophageal cancer
esophageal fistula
Esophageal Fistula - diagnostic imaging
Esophageal Fistula - pathology
Esophageal Neoplasms - diagnostic imaging
Esophageal Neoplasms - pathology
Female
Fistula
Humans
Male
Medical prognosis
Medical records
Middle Aged
Neutrophils
Nomograms
Open source software
Original
Patients
Prognosis
prognostic factors
Proportional Hazards Models
Radiomics
Retrospective Studies
Risk Factors
Statistical analysis
Survival analysis
Tomography, X-Ray Computed
Tumors
title Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A18%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20prognostic%20nomogram%20for%20malignant%20esophageal%20fistula%20based%20on%20radiomics%20and%20clinical%20factors&rft.jtitle=Thoracic%20cancer&rft.au=Zhu,%20Chao&rft.date=2021-12&rft.volume=12&rft.issue=23&rft.spage=3110&rft.epage=3120&rft.pages=3110-3120&rft.issn=1759-7706&rft.eissn=1759-7714&rft_id=info:doi/10.1111/1759-7714.14115&rft_dat=%3Cproquest_doaj_%3E2604953177%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2604953177&rft_id=info:pmid/34647417&rfr_iscdi=true